Colon Cancer Treatment - Response Genetics, Inc. to Announce Pancreatic, Colon and Gastric - MSN MoneyCentral
Response Genetics, Inc. to Announce Pancreatic, Colon and Gastric - MSN MoneyCentral
Response Genetics, Inc. RGDX will announce the results of studies in pancreatic cancer, colon cancer and gastric cancer that identify novel biomarkers and genetic profile patterns that are predictive of therapeutic response. Results of these studies
Significantly Higher Chance Of Surviving Stage III Colon Cancer With - Medical News Today
Sanofi Aventis U.S. announced that the U.S. Food and Drug Administration (FDA) approved the supplemental new drug application (sNDA) to include six-year overall survival analysis from the MOSAIC trial in the Eloxatin (R) (oxaliplatin injection
Runner races against cancer - Honolulu Star-Bulletin
Paul Sibley was worried about a family history of colon cancer when cancer hit him from a different direction. What he thought would be a minor procedure on Jan. 9, 2006, to remove some squamous cells in his face turned out to be 12 hours of surgery
Adding Erbitux To Avastin No Benefit In Colorectal Cancer - CNN Money
CHICAGO -(Dow Jones)- Adding ImClone Systems Inc.’s (IMCL) Erbitux to a treatment regimen that includes Genentech Inc.’s (DNA) Avastin didn’t delay disease progression in colorectal cancer patients, and in fact shortened the time until disease